A detailed history of Virtus Investment Advisers, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 3,800 shares of EXAS stock, worth $261,934. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,800
Previous 3,800 -0.0%
Holding current value
$261,934
Previous $262,000 38.93%
% of portfolio
0.14%
Previous 0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $213,826 - $280,326
3,800 New
3,800 $262,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.